The future of cancer drug manufacturing looks promising with advancements in personalized medicine, where treatments are tailored to individual patients based on their genetic makeup. Innovations in nanotechnology and immunotherapies are also paving the way for more effective and less toxic cancer treatments. Continuous research and collaboration among scientists, clinicians, and regulatory bodies will be essential in overcoming existing challenges and bringing new, life-saving therapies to patients.
